OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PROTACs in the Management of Prostate Cancer
Yedla Poornachandra, Ahmad O. Babalghith, Vindhya Vasini Andra, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3698-3698
Open Access | Times Cited: 13
Yedla Poornachandra, Ahmad O. Babalghith, Vindhya Vasini Andra, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3698-3698
Open Access | Times Cited: 13
Showing 13 citing articles:
PROTACs targeting androgen receptor signaling: Potential therapeutic agents for castration-resistant prostate cancer
Yulu Zhang, Annan Ming, Junyan Wang, et al.
Pharmacological Research (2024) Vol. 205, pp. 107234-107234
Open Access | Times Cited: 7
Yulu Zhang, Annan Ming, Junyan Wang, et al.
Pharmacological Research (2024) Vol. 205, pp. 107234-107234
Open Access | Times Cited: 7
Novel dual-targeting PROTAC degraders of GSK-3β and CDK5: A promising approach for pancreatic cancer treatment
Neerasa Jayaprakash, Byeonggwan Kim, Hye Jin Chung
Bioorganic & Medicinal Chemistry (2025) Vol. 120, pp. 118085-118085
Closed Access
Neerasa Jayaprakash, Byeonggwan Kim, Hye Jin Chung
Bioorganic & Medicinal Chemistry (2025) Vol. 120, pp. 118085-118085
Closed Access
PROTAC technology for prostate cancer treatment
Zhen Wang, Dingpeng Zhang, Hiroyuki Inuzuka, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 1
Open Access
Zhen Wang, Dingpeng Zhang, Hiroyuki Inuzuka, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 1
Open Access
Transcription Factors in Prostate Cancer: Insights for Disease Development and Diagnostic and Therapeutic Approaches
Karla Christina Sousa Silva, Nadine Tambwe, Dalia H. Mahfouz, et al.
Genes (2024) Vol. 15, Iss. 4, pp. 450-450
Open Access | Times Cited: 3
Karla Christina Sousa Silva, Nadine Tambwe, Dalia H. Mahfouz, et al.
Genes (2024) Vol. 15, Iss. 4, pp. 450-450
Open Access | Times Cited: 3
Use of Poly(vinyl alcohol) in Spray-Dried Dispersions: Enhancing Solubility and Stability of Proteolysis Targeting Chimeras
Lena Mareczek, Lena Karin Mueller, Laura Halstenberg, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 924-924
Open Access | Times Cited: 3
Lena Mareczek, Lena Karin Mueller, Laura Halstenberg, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 924-924
Open Access | Times Cited: 3
Glutathione-responsive PROTAC for targeted degradation of ERα in breast cancer cells
Z. Zhou, Heli Fan, Dehao Yu, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 96, pp. 117526-117526
Closed Access | Times Cited: 9
Z. Zhou, Heli Fan, Dehao Yu, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 96, pp. 117526-117526
Closed Access | Times Cited: 9
Molecular heterogeneity in prostate cancer and the role of targeted therapy
Sabiha M. Khan, Prakash Baligar, Chanderdeep Tandon, et al.
Life Sciences (2023) Vol. 336, pp. 122270-122270
Closed Access | Times Cited: 5
Sabiha M. Khan, Prakash Baligar, Chanderdeep Tandon, et al.
Life Sciences (2023) Vol. 336, pp. 122270-122270
Closed Access | Times Cited: 5
Synthesis, SAR, and application of JQ1 analogs as PROTACs for cancer therapy
Soumik De, Raghaba Sahu, Shubhendu Palei, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117875-117875
Closed Access | Times Cited: 1
Soumik De, Raghaba Sahu, Shubhendu Palei, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117875-117875
Closed Access | Times Cited: 1
Retinoblastoma-associated protein is important for TRIM24-mediated activation of the mTOR signaling pathway through DUSP2 action in prostate cancer
Da Ren, Wei Li, Ruijiang Zeng, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 5, pp. 592-604
Closed Access
Da Ren, Wei Li, Ruijiang Zeng, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 5, pp. 592-604
Closed Access
Androgen receptor post-translational modifications and their implications for pathology
Inés Montoya-Novoa, José Luis Gardeazábal-Torbado, Andrea Alegre‐Martí, et al.
Biochemical Society Transactions (2024) Vol. 52, Iss. 4, pp. 1673-1694
Closed Access
Inés Montoya-Novoa, José Luis Gardeazábal-Torbado, Andrea Alegre‐Martí, et al.
Biochemical Society Transactions (2024) Vol. 52, Iss. 4, pp. 1673-1694
Closed Access
PROTAC<sup>®</sup> technology and potential for its application in infection control
M. A. Zakharova, М. В. Чудинов
Fine Chemical Technologies (2024) Vol. 19, Iss. 3, pp. 214-231
Open Access
M. A. Zakharova, М. В. Чудинов
Fine Chemical Technologies (2024) Vol. 19, Iss. 3, pp. 214-231
Open Access
The role of protein post-translational modifications in prostate cancer
Yinghui Hao, Chenqiong Gu, Wenfeng Luo, et al.
PeerJ (2024) Vol. 12, pp. e17768-e17768
Open Access
Yinghui Hao, Chenqiong Gu, Wenfeng Luo, et al.
PeerJ (2024) Vol. 12, pp. e17768-e17768
Open Access
Bavdegalutamide (ARV-110): a potent PROTAC androgen receptor degrader for the treatment of metastatic-castration resistant prostate cancer
Lin Ma, Xin Han
Elsevier eBooks (2024), pp. 357-378
Closed Access
Lin Ma, Xin Han
Elsevier eBooks (2024), pp. 357-378
Closed Access
CRBN‐PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications
Riya Thapa, Asif Ahmad Bhat, Gaurav Gupta, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Open Access
Riya Thapa, Asif Ahmad Bhat, Gaurav Gupta, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Open Access
Protacs in cancer therapy: mechanisms, design, clinical trials, and future directions
Akash Vikal, Rashmi Maurya, Brij Bihari Patel, et al.
Drug Delivery and Translational Research (2024)
Closed Access
Akash Vikal, Rashmi Maurya, Brij Bihari Patel, et al.
Drug Delivery and Translational Research (2024)
Closed Access
